Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hunan Province Cooperative Innovation enter for Molecular Target New Drug Study, Hengyang Medical College, Institute of Pathogenic Biology, University of South China, Hengyang, China.
Changsha Central Hospital, University of South China, Changsha, China.
Immunology. 2021 Oct;164(2):223-230. doi: 10.1111/imm.13346. Epub 2021 May 19.
Mycoplasmas are the smallest and simplest bacteria that lack a cell wall but have the capability of self-replication. Among them, Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia. The hallmark of mycoplasma respiratory diseases is the persistence of lung inflammation that involves both innate and adaptive immune responses. In recent years, a growing body of evidence demonstrates that IL-17 plays an important role in respiratory mycoplasma infection, and associates with the pathologic outcomes of infection, such as pneumonitis and asthma. Numerous studies have shown that a variety of cells, in particular Th17 cells, in the lung can secrete IL-17 during respiratory mycoplasma infection. In this article, we review the biological functions of distinct IL-17-producing cells in mycoplasma respiratory infection with a focus on the effect of IL-17 on the outcomes of infection.
支原体是缺乏细胞壁但具有自我复制能力的最小和最简单的细菌。其中,肺炎支原体是社区获得性肺炎最常见的病因之一。支原体呼吸道疾病的标志是肺炎症的持续存在,涉及固有和适应性免疫反应。近年来,越来越多的证据表明,IL-17 在呼吸道支原体感染中发挥重要作用,并与感染的病理结果相关,如肺炎和哮喘。许多研究表明,在呼吸道支原体感染期间,肺部的多种细胞,特别是 Th17 细胞,可以分泌 IL-17。本文综述了不同的 IL-17 产生细胞在支原体呼吸道感染中的生物学功能,重点关注了 IL-17 对感染结果的影响。